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Surviving the Cytochrome Seas Minireview
cultured cells have shown (Brustugun et al., 1998; Li etDonald D. Newmeyer and Douglas R. Green
al., 1997a; Srinivasan et al., 1998; Zhivotovsky et al.,La Jolla Institute for Allergy and Immunology
1998). Cell lines were found to vary in their sensitivity10355 Science Center Drive
to killing by microinjected cytochrome c. Even for theSan Diego, California 92121
sensitive cells, moreover, the intracellular concentra-
tions of cytochrome c needed for cell killing (2±10 mM)
were an order of magnitude higher than those requiredIn the molecular drama of apoptotic cell death, perhaps
to activate caspases in cell extracts (0.2±0.5 mM). Intactthere is no character stranger than cytochrome c. This
cells thus seem to have a way to regulate or suppress thefamiliar heme protein can be transformed, in Jekyll and
response to cytosolic cytochrome c. When apoptosis isHyde fashion, from life-sustainer into life-destroyer. Nor-
induced, the inhibitory effect is removed; this suppres-mally, cytochrome c is restricted to the intermembrane
sion is also apparently lost during the preparation ofspace of mitochondria, where it plays a well-known role
cell extracts. Are the cell-free systems merely artifactualin the electron transport chain. In many cases, though,
in this regard, or is there a hint of something still to beearly in apoptosis, an ill-defined mitochondrial lesion
learned here about apoptotic regulation in vivo?allows this protein to escape into the cytosol (Liu et al.,
This question has now been brought sharply into fo-1996; Bossy-Wetzel et al., 1998; Kim et al., 1997; Kluck
cus in a new study by Deshmukh and Johnson (1998 [thiset al., 1997; Vander Heiden et al., 1997; Yang et al., 1997;
issue of Neuron]) regarding the effects of cytochrome cPastorino et al., 1998). What it does there, as suggested
microinjection into primary sympathetic neurons. Theseby biochemical experiments (Liu et al., 1996; Li et al.,
cells require the continuous presence of nerve growth1997b), is to interact with the cytosolic factors Apaf-1
factor (NGF) for survival; after the withdrawal of trophicand procaspase-9, leading to the aggregation and trans-
factor, they die by apoptosis within z24 hr. Expressionactivation of the latter. The active caspase-9, in turn,
of the BAX protein is required for cell death followingprocesses the ªexecutionerº caspases (proteases im-
NGF deprivation, because neurons from BAX-deficientportant for the execution phase of apoptosis). This
mice survive for at least several weeks in the absenceªkillerº role for cytochrome c is further supported by the
of the growth factor. Cell death also requires proteinphenotype of mice nullizygous for caspase-9 (Hakem et
synthesis, as treatment with cycloheximide (CHX) res-al., 1998; Kuida et al., 1998) or Apaf-1 (Cecconi et al.,
cues the cells from death following NGF withdrawal.1998; Yoshida et al., 1998). These mice are defective in
Since BAX expression is required for cell death followingmany (but not all) forms of apoptosis. The effects of
NGF withdrawal, the effect of CHX may be at the leveldeficiency in caspase-9 (Hakem et al., 1998; Kuida et
of expression of this protein.al., 1998) or the downstream target caspase-3 are severe
In this new study, sympathetic neurons maintained inin the developing brain, which literally bursts through
NGF were found to be resistant to killing by microin-the skull due to excess neuronal mass. In animals lack-
jected cytochrome c. On the other hand, neurons de-ing Apaf-1, there is a delay in the loss of the interdigital
prived of NGF, but kept alive either because they lackedwebs, hyperplasia of neurons and retinal cells, defects
BAX or were treated with CHX, failed to release cyto-in the formation of the lens and palate, and many other
chrome c from their mitochondria but did die in responsedevelopmental consequences (Cecconi et al., 1998;
to cytochrome c injection. Deshmukh and Johnson con-Yoshida et al., 1998). Unless the Apaf-1/caspase-9 path-
clude that there are two processes contributing to theway can somehow be activated independently of cyto-
apoptotic death of sympathetic neurons. One of thesechrome c, these results argue for a broad (although not
is the release of cytochrome c from mitochondria, anduniversal) role of cytochrome c in apoptotic cell death.
the other is the development of what they call ªcompe-The exquisite sensitivity of cell extracts to cytochrome
tence-to-die,º defined as the ability of the cell to undergoc has provoked a simple hypothesis that all the cell
apoptosis in response to the presence of extramito-needs to do to regulate apoptosis is to control the efflux
chondrial cytochrome c. NGF signals a block to both ofof cytochrome c from its mitochondria. In support of
these processes. When NGF is withdrawn, however, thethis idea, studies both in intact cells and in cell-free
two processes occur coordinately and may be regulatedsystems showed that the BCL-2 and BCL-XL proteins independently (see Figure 1).prevent cell death, at least in part, by preventing the
What does competence-to-die entail, in moleculartranslocation of cytochrome c (Kim et al., 1997; Kluck
terms? We don't really know. One could guess that com-et al., 1997; Vander Heiden et al., 1997; Yang et al., 1997;
petence-to-die reflects the intracellular accumulation of
Srinivasan et al., 1998). BAX, a pro-apoptotic counter-
dATP, a cofactor of Apaf-1. However, microinjection of
part of BCL-2 and BCL-XL, may lead to cell death through dATP along with cytochrome c did not confer compe-
the opposite activity of promoting cytochrome c release
tence-to-die on neurons cultured in NGF. Another possi-
(Juergensmeier et al., 1998; Pastorino et al., 1998).
bility is that NGF signals the posttranslational modifica-
However, the full story is not so simple, as experi-
tion of one or more of the components of the Apaf-1/
ments in which cytochrome c was microinjected into caspase-9 pathway, at or downstream from the point
where cytochrome c acts. However, in the presence of
CHX, a 30 min treatment of trophic factor±deprived cells* To whom correspondence should be addressed (e-mail: dgreen
5240@aol.com). with NGF prior to cytochrome c injection was unable to
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Figure 1. A Model for the Regulation of Apo-
ptosis in Neurons
Upon withdrawal of NGF, a signal is gener-
ated (or derepressed) which depends on the
expression of BAX and activates this mole-
cule to participate in the apoptotic process.
BAX translocates to mitochondria and trig-
gers the release of cytochrome c. In the cyto-
sol, cytochrome c associates with Apaf-1,
which then binds procaspase-9 to form a ver-
tebrate apoptosome. Procaspase-9 transac-
tivates, and the active caspase then cleaves
and activates downstream caspases (3, 6,
and 7), which in turn cleave key substrates
to orchestrate apoptosis. In the presence of
NGF, a signal is generated that results in inhi-
bition of apoptosome formation or function,
such that cytosolic cytochrome c does not
cause cell death. Presumably, this is medi-
ated via expression of an inhibitor.
rescue the cells. Thus, the reversal of competence-to- not required, because neurons can develop compe-
tence-to-die even when CHX is present. It is likely, there-die appears to require more than the mere activation of
fore, that upon removal of NGF, the cells cease pro-the NGF signaling pathway.
duction of the proposed inhibitor of the cytochromeLogically, there are three general ways in which NGF
c/Apaf-1/procaspase-9 apoptosome. Additionally, themay inhibit the susceptibility of the cell to cytosolic
NGF-deprived cells may now permit BAX activity tocytochrome c. Sustained NGF signaling might modify
manifest, when it translocates to the mitochondria toone of the three components (procaspase-9, Apaf-1, or
trigger the release of cytochrome c. Evidence has beencytochrome c itself), might inhibit the activity of the
presented that the unligated p75 NGFR generates a sig-caspase (needed not only for downstream signaling but
nal, which is inhibited by the presence of NGF (Rabiza-also for cytochrome c±triggered transactivation), or
deh et al., 1993). If so, then it is possible that this signalmight regulate a hypothetical second signal (which is
is responsible for inducing BAX function.present in extracts but not in the cytosol of viable cells).
The concept of competence-to-die gives us a possibleCandidates for the second possibility exist in the form
framework for understanding the varied sensitivities ofof the inhibitor of apoptosis proteins (IAPs), including
cells to microinjected cytochrome c. We can speculate
XIAP. XIAP is a potent inhibitor of caspase-9 and can
that some spatially organized feature of intact cells, lost
thereby interfere with its activation via cytochrome upon preparation of cytosolic extracts, such as the cy-
c/Apaf-1 (Deveraux et al., 1998). If the levels of these toskeleton, the endomembrane system, or the plasma
proteins are dependent on the presence of NGF, it is membrane, contributes a signal that inhibits the pro-
possible that this may account for the resistance of apoptotic activity of cytochrome c. Of the structured
NGF-treated neurons to microinjected cytochrome c. It components in the cell, the endoplasmic reticulum may
is not clear, however, why the effects of such proteins be the best candidate, because it has already shown to
should be lost upon preparation of cell-free extracts, be a site for BCL-2 regulation of apoptosis (Zhu et al.,
since they have been shown to function in vitro. 1996). This would help to explain why cells expressing
The death-permissive state induced by NGF with- BCL-2 appear to be more resistant to the effects of
drawal requires 16±18 hr to develop. This suggests that microinjected cytochrome c (Zhivotovsky et al., 1998).
a slow process such as the degradation of a preexist- In addition to inhibiting cytochrome c release, we may
speculate that BCL-2 (on the ER?) inhibits cellularing macromolecule is responsible. Protein synthesis is
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changes that make a cell competent to receive the cyto-
chrome c signal.
The simple model of apoptosis in which the release
of cytochrome c from mitochondria was both necessary
and sufficient for some forms of cell death was attractive
and helped to explain many features of apoptosis regu-
lation. But, like many simple models, it served its pur-
pose and will now have to be put aside in favor of new
models that accommodate emerging complexity in the
system. Clearly, we have much to learn about the addi-
tional signals that regulate the response to cytosolic
cytochrome c and thereby control the life and death of
neurons (and probably other cells). For the present, a
fog has settled over the cytochrome seas, but when it
lifts who knows what marvelous new regions there will
be to explore?
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